CLINICAL TRIALS PROFILE FOR MECLOFENAMATE SODIUM

All Clinical Trials for MECLOFENAMATE SODIUM

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02017197 ↗	Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil	Completed	Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4	2014-08-01	The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.
NCT02017197 ↗	Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil	Completed	Federal University of São Paulo	Phase 4	2014-08-01	The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.

Clinical Trial Conditions for MECLOFENAMATE SODIUM

Condition Name

Condition Name for MECLOFENAMATE SODIUM
Intervention	Trials
Atrial Fibrillation	1

Condition MeSH

Condition MeSH for MECLOFENAMATE SODIUM
Intervention	Trials
Atrial Fibrillation	1

Clinical Trial Locations for MECLOFENAMATE SODIUM

Trials by Country

Trials by Country for MECLOFENAMATE SODIUM
Location	Trials
Brazil	1

Clinical Trial Progress for MECLOFENAMATE SODIUM

Clinical Trial Phase

Clinical Trial Phase for MECLOFENAMATE SODIUM
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for MECLOFENAMATE SODIUM
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for MECLOFENAMATE SODIUM

Sponsor Name

Sponsor Name for MECLOFENAMATE SODIUM
Sponsor	Trials
Fundação de Amparo à Pesquisa do Estado de São Paulo	1
Federal University of São Paulo	1

Sponsor Type

Sponsor Type for MECLOFENAMATE SODIUM
Sponsor	Trials
Other	2